Your Article Summary
See Latest ArticlesSpontaneous regression of primary cutaneous Epstein-Barr virus-positive, CD30-positive anaplastic large T-cell lymphoma in a heart-transplant recipient
Clinical and Experimental Dermatology, 06/16/09
Chiu LS et al. - The authors presented a rare case of primary cutaneous Epstein-Barr virus-positive, CD30-positive anasplastic large cell lymphoma in a 64-year-old man who had received a heart transplant 11 years previously. The first presenting symptom was the appearance of erythematous skin nodules on the right leg. The lesions subsided with dose reduction of immunosuppressant alone. There was no recurrence 9 months after the first diagnosis.
Related Articles
Epstein-Barr virus–positive diffuse large B-cell lymphoma in elderly patients is rare in Western populations
Human Pathology, 11/19/09
Relevance Score: 64%
Cell cycle arrest induced by engagement of B7-H4 on Epstein–Barr virus-positive B-cell lymphoma cell lines
Immunology, 10/08/09
Relevance Score: 64%
Nucleosome Assembly Proteins Bind to Epstein-Barr Virus Nuclear Antigen 1 and Affect Its Functions in DNA Replication and Transcriptional Activation
Journal of Virology, 10/27/09
Relevance Score: 42%
General and Target-Specific RNA Binding Properties of Epstein-Barr Virus SM Posttranscriptional Regulatory Protein
Journal of Virology, 10/26/09
Relevance Score: 42%
Functional Interaction between Epstein-Barr Virus Replication Protein Zta and Host DNA Damage Response Protein 53BP1
Journal of Virology, 10/13/09
Relevance Score: 42%
Today in Transplant/Augmentation...keeping you current
Receive free subspecialty "5-minute updates" via email
Percutaneous coronary intervention using drug-eluting stents in pediatric heart transplant recipients
Pediatric Transplantation, 12/15/09
Should we perform heart retransplantation in early graft failure
Transplant International, 12/14/09
Outcomes of Pediatric Patients With Hypertrophic Cardiomyopathy Listed for Transplant
The Journal of Heart and Lung Transplantation, 12/09/09